Sigounas, GeorgeMehlhop, Paul2019-11-112019-11-112002-10-17Canada Patent # CA2443025A1US Pat# US28262101Phttp://hdl.handle.net/10342/7535Application abandoned?A method of reducing organ toxicity in a subject being administered a cytotoxic agent comprising concurrently administering with the cytotoxic agent erythropoietin (EPO), the EPO being administered in an amount effective to reduce pulmonary toxicity caused by the cytotoxic agent.en-UScytotoxicityPatent